146 related articles for article (PubMed ID: 710365)
1. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats.
Rapp JP; Tan SY; Margolius HS
Endocr Res Commun; 1978; 5(1):35-41. PubMed ID: 710365
[TBL] [Abstract][Full Text] [Related]
2. Anomalous response of urinary kallikrein to deoxycorticosterone in Dahl salt-sensitive rats.
Rapp JP; McPartland RP; Sustarsic DL
Hypertension; 1982; 4(1):20-6. PubMed ID: 6916711
[TBL] [Abstract][Full Text] [Related]
3. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
[TBL] [Abstract][Full Text] [Related]
4. Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
Witzgall H; Hassan-Ali S
J Chromatogr; 1980 Sep; 198(1):70-5. PubMed ID: 7430313
[TBL] [Abstract][Full Text] [Related]
5. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
7. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
Witzgall H; Thayil G; Weber PC
Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
[TBL] [Abstract][Full Text] [Related]
8. Steroid induced changes of the renal kallikrein-kinin system in rats.
Bönner G; Autenrieth R; Marin-Grez M; Speck G; Gross F
Acta Endocrinol (Copenh); 1984 Sep; 107(1):131-40. PubMed ID: 6091386
[TBL] [Abstract][Full Text] [Related]
9. Effect of ACTH administration on urinary kallikrein excretion in man.
Whitworth JA; van Leeuwen BH; Hannah MC; Scoggins BA; Thatcher R
Clin Exp Pharmacol Physiol; 1984; 11(1):87-90. PubMed ID: 6325055
[TBL] [Abstract][Full Text] [Related]
10. Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.
Fritschka E; Gotzen R; Kittler R; Schöneshöfer M
Br J Pharmacol; 1984 Feb; 81(2):245-53. PubMed ID: 6367871
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein excretion in Dahl salt-sensitive and salt-resistant rats with native and transplanted kidneys.
Churchill PC; Churchill MC; Bidani AK; Rabito SF
Am J Physiol; 1995 Nov; 269(5 Pt 2):F710-7. PubMed ID: 7503238
[TBL] [Abstract][Full Text] [Related]
12. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
[TBL] [Abstract][Full Text] [Related]
13. Urinary free 18-hydroxy-11-desoxycorticosterone excretion in normal and hypertensive patients.
Agrin RJ; Dale SL; Holbrook M; LaRossa JT; Melby JC
J Clin Endocrinol Metab; 1978 Oct; 47(4):877-84. PubMed ID: 233684
[TBL] [Abstract][Full Text] [Related]
14. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
[TBL] [Abstract][Full Text] [Related]
15. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
[TBL] [Abstract][Full Text] [Related]
16. 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and salt-resistant (R/JR) Dahl rats.
Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 1988 Mar; 122(3):1110-3. PubMed ID: 3342746
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies.
Bouhnik J; Richoux JP; Huang H; Savoie F; Baussant T; Alhenc-Gelas F; Corvol P
Clin Sci (Lond); 1992 Jul; 83(1):13-22. PubMed ID: 1325316
[TBL] [Abstract][Full Text] [Related]
19. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
Roger M; Nahoul K; Laloy E; Scholler R
Ann Med Interne (Paris); 1983; 134(3):238-41. PubMed ID: 6625419
[TBL] [Abstract][Full Text] [Related]
20. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Melby JC; Dale SL
Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
